Pharma
Jubilant Pharmova swings to Q1 profit of Rs 47.6 crore from year-ago loss
BullishPharma
Jubilant Pharmova posted a consolidated net profit of Rs 47.6 crore for the quarter ended June 30, 2026, a significant turnaround from a net loss of Rs 65.7 crore a year earlier. Total income for the quarter stood at Rs 1,666 crore, a slight increase from Rs 1,656.6 crore YoY. The company's basic EPS was Rs 2.99, compared to a loss per share of Rs 4.13 in the prior year.
Premium Signal
Subscribe to ResearchAmp Sherpa for full access to all intelligence signals, including body content, filters, and unlimited scrolling.
View Plans